Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
OMGA
13301
CALL
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $7.2K | ﹤0.01% |
5,900
-11,400
| -66% | -$18.2K |
2024 Q1
2 quarters
|
|
13302
CALL
Lifetime Brands
LCUT
$208M
| $7.19K | ﹤0.01% |
1,100
-2,000
| -65% | -$14.7K |
2022 Q4
7 quarters
|
|
13303
CALL
Acumen Pharmaceuticals
ABOS
$154M
| $7.19K | ﹤0.01% |
2,900
-1,100
| -28% | -$2.98K |
2022 Q3
8 quarters
|
|
|
NBP
13304
PUT
NovaBridge Biosciences American Depositary Shares
NBP
$157M
| $7.19K | ﹤0.01% |
5,800
+3,900
| +205% | +$4.88K |
2022 Q4
7 quarters
|
|
13305
PUT
Oric Pharmaceuticals
ORIC
$1.29B
| $7.17K | ﹤0.01% |
+700
| New | +$6.92K |
2024 Q3
0 quarters
|
|
13306
CALL
TROOPS Inc
TROO
$200M
| $7.16K | ﹤0.01% |
+2,100
| New | +$7.73K |
2024 Q3
0 quarters
|
|
|
BORR
13307
CALL
Borr Drilling
BORR
$1.28B
| $7.14K | ﹤0.01% |
1,300
| – | – |
2024 Q1
2 quarters
|
|
13308
PUT
Equity Lifestyle Properties
ELS
$11.4B
| $7.13K | ﹤0.01% |
100
-74,800
| -100% | -$5.24M |
2022 Q4
7 quarters
|
|
13309
Eve Holding
EVEX
$592M
| $7.12K | ﹤0.01% |
2,197
-6,185
| -74% | -$18.7K |
2024 Q2
1 quarter
|
|
|
TBI
13310
PUT
Trueblue
TBI
$271M
| $7.1K | ﹤0.01% |
900
+800
| +800% | +$7.2K |
2024 Q2
1 quarter
|
|
13311
CALL
INVE Technologies, Inc. Common Stock
INVE
$57M
| $7.06K | ﹤0.01% |
2,000
+1,900
| +1,900% | +$6.95K |
2022 Q4
7 quarters
|
|
13312
PUT
Acadia Realty Trust
AKR
$2.53B
| $7.04K | ﹤0.01% |
300
-400
| -57% | -$8.53K |
2022 Q4
7 quarters
|
|
13313
DHT Holdings
DHT
$3.84B
| $7.04K | ﹤0.01% |
638
-228,194
| -100% | -$2.52M |
2020 Q3
16 quarters
|
|
13314
PUT
LXP Industrial Trust
LXP
$3.59B
| $7.04K | ﹤0.01% |
140
-60
| -30% | -$3K |
2022 Q4
7 quarters
|
|
|
KNDI
13315
PUT
Kandi Technologies Group
KNDI
$70.8M
| $7K | ﹤0.01% |
3,400
-9,300
| -73% | -$16.9K |
2013 Q2
45 quarters
|
|
13316
PUT
Grid Dynamics Holdings
GDYN
$636M
| $7K | ﹤0.01% |
500
-1,800
| -78% | -$23.3K |
2024 Q2
1 quarter
|
|
|
FARM
13317
CALL
DELISTED
Farmer Brothers
FARM
| $6.93K | ﹤0.01% |
3,500
+2,300
| +192% | +$5.9K |
2022 Q4
7 quarters
|
|
13318
CALL
Star Holdings Shares of Beneficial Interest
STHO
$106M
| $6.92K | ﹤0.01% |
500
-10,600
| -95% | -$137K |
2023 Q2
5 quarters
|
|
|
LGO
13319
PUT
Largo
LGO
$54.9M
| $6.9K | ﹤0.01% |
3,300
-500
| -13% | -$932 |
2022 Q4
7 quarters
|
|
13320
CALL
NRC Health Common Stock
NRC
$460M
| $6.86K | ﹤0.01% |
300
+100
| +50% | +$2.26K |
2024 Q2
1 quarter
|
|
|
13321
PUT
NRC Health Common Stock
NRC
$460M
| $6.86K | ﹤0.01% |
300
-100
| -25% | -$2.26K |
2024 Q2
1 quarter
|
|
13322
CALL
Kyverna Therapeutics
KYTX
$391M
| $6.85K | ﹤0.01% |
1,400
-4,500
| -76% | -$34.7K |
2024 Q1
2 quarters
|
|
|
IRS
13323
CALL
IRSA Inversiones y Representaciones
IRS
$1.18B
| $6.83K | ﹤0.01% |
+622
| New | +$6.11K |
2024 Q3
0 quarters
|
|
|
SACH
13324
PUT
Sachem Capital Corp
SACH
$43.2M
| $6.8K | ﹤0.01% |
2,700
-2,100
| -44% | -$5.3K |
2024 Q1
2 quarters
|
|
13325
CALL
Ascent Industries
ACNT
$123M
| $6.79K | ﹤0.01% |
+700
| New | +$6.88K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.